News Sentiment

JUNS sentiment intelligence

Jupiter Neurosciences, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.17 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-9.2% over one week, -27.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -9.2% Price reacting lower
Trend fit Trend inactive -27.5% over four weeks
Fair value -88.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 37
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 21
Stock Titan 6
TradingView 6
Investing News Network 2
Moomoo 2
simplywall.st 2
IPO-Edge.com 1
Mugglehead Investment Magazine 1

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 15
Deals and strategy 8
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63
scanx.trade Direct company coverage

Jupiter Neurosciences files for resale of up to 16M shares by Yorkville

Jupiter Neurosciences, Inc. has filed a prospectus for the resale of up to 16 million shares by YA II PN, LTD (Yorkville) under a standby equity purchase agreement. While the company will not receive proceeds from this specific resale, it has the potential to receive up to $17.2

Tone
Negative 39/100
Event
Market update
Published
26 Jun 2026 21:40
Source
scanx.trade
Stock Titan Direct company coverage

Yorkville to resell 16M Jupiter Neurosciences (NASDAQ: JUNS) shares under SEPA

Jupiter Neurosciences has registered 16 million shares of common stock for resale by Yorkville under a Standby Equity Purchase Agreement (SEPA), which could provide up to $20 million in equity financing. This move could lead to significant dilution for existing shareholders, as t

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:40
Source
Stock Titan
TradingView Direct company coverage

Jupiter Neurosciences, Inc. Actuals & Estimates (NASDAQ:JUNS)

This article provides a detailed overview of Jupiter Neurosciences, Inc. (JUNS) stock, including its current price, market capitalization, volatility, and historical performance. It also covers financial actuals and estimates, confirming that the company does not pay dividends an

Tone
Negative 40/100
Event
Market update
Published
25 Jun 2026 14:39
Source
TradingView
Finviz Direct company coverage

JUNS - Jupiter Neurosciences Inc Earnings

This article provides a detailed financial overview and key performance indicators for Jupiter Neurosciences Inc. (JUNS). It includes data on market capitalization, enterprise value, income, sales, various P/E and P/S ratios, debt metrics, insider ownership, profitability margins

Tone
Negative 42/100
Event
Earnings
Published
25 Jun 2026 02:10
Source
Finviz